FFA
NVO

Farther Finance Advisors’s Novo Nordisk NVO Stock Holding History

Farther Finance Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98M Sell
83,020
-4,035
-5% -$173K 0.03% 472
2026
Q1 		$3.18M Buy
87,055
+13,954
+19% +$661K 0.03% 485
2025
Q4 		$3.72M Sell
73,101
-9,036
-11% -$462K 0.04% 387
2025
Q3 		$4.56M Sell
82,137
-21,001
-20% -$1.23M 0.07% 241
2025
Q2 		$7.12M Buy
103,138
+33,794
+49% +$2.3M 0.14% 133
2025
Q1 		$4.72M Buy
69,344
+19,061
+38% +$1.57M 0.12% 162
2024
Q4 		$4.33M Buy
50,283
+20,546
+69% +$2.22M 0.16% 117
2024
Q3 		$3.54M Buy
29,737
+3,137
+12% +$418K 0.13% 134
2024
Q2 		$3.87M Sell
26,600
-292
-1% -$38.7K 0.19% 91
2024
Q1 		$3.43M Sell
26,892
-7,030
-21% -$837K 0.21% 91
2023
Q4 		$3.51M Buy
33,922
+29,425
+654% +$2.91M 0.25% 79
2023
Q3 		$409K Buy
4,497
+4,435
+7,153% +$391K 0.06% 231
2023
Q2 		$5.02K Sell
62
-68
-52% -$5.55K ﹤0.01% 1433
2023
Q1 		$10.3K Buy
130
+92
+242% +$6.52K ﹤0.01% 1099
2022
Q4 		$2.57K Buy
+38
New +$2.23K ﹤0.01% 1368

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Farther Finance Advisors's NVO Position: Q2 2026 in Review

Farther Finance Advisors reduced its Novo Nordisk (NVO) stake by 4.6% in Q2 2026, selling an estimated $173K and leaving 83,020 shares worth $3.98M. The position accounts for 0.03% of the portfolio, ranked #472.

Farther Finance Advisors first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.12M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Farther Finance Advisors held 83,020 shares of Novo Nordisk worth $3.98M as of Q2 2026.
  • Farther Finance Advisors sold 4,035 Novo Nordisk shares in Q2 2026, an estimated $173K.
  • Novo Nordisk made up 0.03% of Farther Finance Advisors's portfolio in Q2 2026, its #472 holding.
  • Farther Finance Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Novo Nordisk position peaked at $7.12M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.